Skip to main content
. 2023 Aug 25;11(9):852–860. doi: 10.1002/ueg2.12452

TABLE 2.

Overall mortality outcomes in Wilson's disease patients and reference individuals.

Wilson's disease Reference individuals HR (95%CI)
N Deaths, N (%) Mortality per 1000 person‐years (95% CI) N Deaths, N (%) Mortality per 1000 person‐years (95% CI)
All 151 10 (6.6) 8.53 (4.59–15.85) 1441 31 (2.2) 2.53 (1.78–3.60) 3.84 (1.84–8.05)
Men 76 5 (6.6) 8.04 (3.35–19.31) 728 13 (1.8) 1.99 (1.16–3.43) 3.53 (1.26–9.92)
Women 75 5 (6.7) 9.09 (3.78–21.84) 713 18 (2.5) 3.15 (1.98–5.00) 4.22 (1.46–12.14)
Age <20 years at baseline 50 0 (0.0) 0 495 2 (0.4) 0.58 (0.14–2.30)
Age ≥20 years at baseline 101 10 (9.9) 11.83 (6.37–22.00) 946 29 (3.1) 3.31 (2.30–4.76) 4.17 (1.97–8.82)
Wilson's disease, born in Sweden 102 8 (9.4) 9.80 (4.90–19.60) 980 22 (2.2) 2.63 (1.73–3.99) 3.95 (1.73–9.02)
Wilson's disease, born outside Sweden 49 2 (4.1) 5.62 (1.41–22.47) 461 9 (2.0) 2.33 (1.21–4.48) 3.47 (0.67–18.00)
Neuropsychiatric condition 50 7 (14.0) 20.72 (9.88–43.47) 483 14 (2.9) 3.79 (2.25–6.40) 7.87 (2.85–21.75)
No neuropsychiatric condition 101 3 (3.0) 3.60 (1.16–11.15) 958 17 (1.8) 1.99 (1.24–3.20) 1.77 (0.52–6.07)

Abbreviations: CI, confidence interval; HR, hazard ratio.